Sign in
IN Stock Price, Chart, Stats & News
InMed Pharmaceuticals Inc.
Save
InMed Pharmaceuticals Inc. (IN) does not currently pay a dividend.
–
Market cap
–
Current P/E
–
Forward P/E
IN chart
1M
3M
1Y
5Y
Loading chart...
About
Health care
Sector
Biotechnology
Industry
InMed Pharmaceuticals Inc. is a clinical-stage pharmaceutical company dedicated to discovering and advancing cannabinoid-based therapeutic solutions. Their primary drug candidate, INM-755, a cannabinol topical cream, is currently progressing through its second Phase I clinical trial for individuals suffering from epidermolysis bullosa. The company's pipeline also includes INM-088, which is undergoing preclinical investigations for glaucoma, and INM-405, under development for pain relief.
Similar securities
Based on sector and market capitalization
Report issue